结果:包括12,990例随机分配给10种药理学干预措施和安慰剂的患者的25例RCT。与安慰剂相比,关于生殖器感染(GI)(GI),所有SGLT-2I,除Ertugli lopli ozin和ipragli lof ozin外,与GI的风险更高有关。empagli -lof ozin 10mg/d(88.2%,优势比[OR] 7.90,95%可信间隔[CRI] 3.39至22.08)可能是最危险的基于概率排名,300mg/d(70.8%或5.33,95%CRI 2.25至13.83)。此外,与尿路感染(UTI或2.11,95%CRI 1.20至3.79,87.2%),肾脏损伤(80.7%)和鼻咽炎(81.6%)相比,与尿路感染(UTI或2.11,95%CRI 1.20至3.79,87.2%)相比,Dapagli -lof ozin 10mg/d排名最高。没有观察到
ASEAN Association of Southeast Asian Nations BDS Basin Development Strategy BfG Federal Institute for Hydrology BMVI German Federal Ministry of Transport CCAI Climate Change and Adaptation Initiative CDM Clean Development Mechanism CHR International Commission for the Hydrology of the Rhine Basin CNMCS Cambodia National Mekong Committee Secretariat DSF Decision Support Framework FMMP Flood Management and Mitigation Programme GFCS German Federal Ministry of Transport ICPR International Commission for protection of the Rhine IKMP Information and Knowledge Management Programme IPCC Intergovernmental Panel on Climate Change IQQM Integrated Water Quantity and Quality Simulation Model IWRM Integrated Water Resources Management LNMCS Lao National Mekong Committee Secretariat MASAP Mekong Adaptation Strategy and Action Plan MRC Mekong River Commission NAPA National Adaptation Programme of Action to Climate Change PPCR Pilot Programme for Climate Resilience SIMVA Social Impact Monitoring脆弱性评估TNMCS泰国国家湄公河委员会秘书处VNMCS越南国家湄公河委员会秘书处WMO WMO世界气象组织WSV联邦水道和航运公司